Sort
10,766 grants matching “checkpoint inhibitor”
Lynch Vaccine
$441,081Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · U54 · FY2022 · CA
Novel mechanisms regulating PD-1 signaling and function
$441,015Adam Mor · Columbia University Health Sciences · R01 · FY2025 · AI
Immunostimulatory Nanocarrier for Breast Cancer Immunochemotherapy
$440,990Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Targeting immune suppressive microenvironment in ATC
$440,718James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Targeting immune suppressive microenvironment in ATC
$440,718James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Exploration of different immunotherapy modalities in osteosarcoma
$440,640Payal Agarwal · Auburn University At Auburn · R15 · FY2023 · CA
Effect of DNA repeat silencing on efficacy of ATRi in prostate cancer treatment
$440,628Eric J Brown · University Of Pennsylvania · R01 · FY2024 · CA
Engineered Ensemble Nanoimmunotherapies for Cancer
$440,543Rohan Fernandes · George Washington University · R37 · FY2019 · CA
Mechanisms of therapeutic efficacy of BAFF inhibition using belimumab
$440,538Anne Davidson · Feinstein Institute For Medical Research · R01 · FY2016 · AR
Mechanisms of therapeutic efficacy of BAFF inhibition using belimumab
$440,538Anne Davidson · Feinstein Institute For Medical Research · R01 · FY2017 · AR
Mechanisms of therapeutic efficacy of BAFF inhibition using belimumab
$440,538Anne Davidson · Feinstein Institute For Medical Research · R01 · FY2014 · AR
Mechanisms of therapeutic efficacy of BAFF inhibition using belimumab
$440,538Anne Davidson · Feinstein Institute For Medical Research · R01 · FY2018 · AR
Mechanisms of therapeutic efficacy of BAFF inhibition using belimumab
$440,538Anne Davidson · Feinstein Institute For Medical Research · R01 · FY2015 · AR
An integrated polymeric carrier for subunit cancer vaccines
$440,520Suzie H Pun · University Of Washington · R01 · FY2022 · CA
DNA Methylation Inhibitor Therapy for Testicular Cancer
$440,311Michael J Spinella · University Of Illinois At Urbana-Champaign · R01 · FY2022 · CA
Lung Cancer Vaccine
$440,288Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · U54 · FY2023 · CA
Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface
$440,245Melody A Swartz · University Of Chicago · R01 · FY2025 · CA
Optimizing pre-analytical variables for reliable mass spectrometry-based quantification of immunomodulatory proteins in cerebrospinal fluid in pediatric neuro-oncology trials
$440,171Amanda G Paulovich · Fred Hutchinson Cancer Center · U01 · FY2025 · CA
Multiscale analysis of metabolic inflammation as a driver of breast cancer
$440,153Gerald V Denis · Boston University Medical Campus · U01 · FY2024 · CA
Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
$440,121Jonathan Maybaum · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Project 2: Combination PARPi-BETi to Overcome PARPi Resistance
$440,092Haider Mahdi · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · CA
Regulation of the cell cycle by SCF and APC/C ubiquitin ligases
$440,071Michele Pagano · New York University School Of Medicine · R01 · FY2013 · GM
Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation
$440,000Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2023 · NS
Laser Interstitial Thermal Therapy for the Treatment of Glioblastoma
$440,000Ganesh Rao · Baylor College Of Medicine · R21 · FY2021 · NS
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2
$440,000Jane C. Figueiredo · Cedars-Sinai Medical Center · U54 · FY2022 · CA